Genome editing. The new frontier of genome engineering with CRISPR-Cas9.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25430774.
- Also identified by DOI 10.1126/science.1258096.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Medical subject headings
- Clustered Regularly Interspaced Short Palindromic Repeats
- Genetic Engineering
- Genome, Human